glp 1 help with depression GLP‑1 Depression: Can These Drugs Boost Mood? Reassuring' findings suggest GLP-1 receptor

Lixisenatide and exenatide have the same effect as liraglutide in AD models (84, 141, 144, 148, 157, 179, 206, 213)

Whereas corticosteroids and biologics affect immune system and may expose patients to adverse effects such as infections, GLPs do not act directly as immunosuppressants and may become first-line therapy in the treatment of IBD

Increasing payer support and reimbursement coverage, enabling broader patient access and long-term market growth Government Initiatives Supporting the Obesity GLP-1 Market As obesity is increasingly recognized as a chronic, high-burden disease, government initiatives are playing a key role in supporting the obesity GLP-1 market

The impact is especially clear in categories like: GLP-1s (for weight management and diabetes) Dermatology (including telemedicine platforms like Musely) Hormone replacement therapy (HRT) Thyroid and adrenal care Pain management Veterinary and ophthalmic treatments Demand for compounding is surging, and the system isnt sure how to keep up

The honest framing right now: encouraging, but not yet established for this population

Another phase II trial by Sanyal et al